S-cubed Pharmaceutical Services ApS: Financial statements 2023
CVR: 39035448
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
S-cubed Pharmaceutical Services ApS (CVR 39035448) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 4,245 and a net result of DKK 4,057 compared with DKK 174,554 the year before. That is a decrease of 98.2% compared with the year before. Equity in the 2023 report amounted to DKK 651,453. The solvency ratio was 97.9%.
- Gross Profit
- DKK 4,245
- Profit/Loss
- DKK 4,057
- Equity
- DKK 651,453
- Total Assets
- DKK 665,510
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 4K | 4K | 651K | - |
| 2022 | - | 237K | 175K | 647K | - |
| 2021 | - | 397K | 323K | 473K | 1 |
| 2020 | - | 146K | 142K | 150K | 1 |
| 2019 | - | 475K | -207K | 7K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
S-cubed Pharmaceutical Services ApS has published its annual report for 2022. Gross profit came to DKK 236,509, and the net result was DKK 174,554.
About S-cubed Pharmaceutical Services ApS
S-cubed Pharmaceutical Services ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2017. The company is registered under the industry Anden teknisk rådgivning. The management consists of Mark Dennis Lipscombe. The company is owned by S-Cubed Limited. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,235 and a net result of DKK -959 compared with DKK -51,181 the year before. Equity in the 2025 report amounted to DKK 599,313.